EP Patent

EP4427742A1 — Pharmaceutical compositions comprising dapagliflozin and metformin

Assigned to Galenicum Health SL · Expires 2024-09-11 · 2y expired

What this patent protects

The present invention relates to a uniform pharmaceutical composition comprising dapagliflozin, metformin, at least one acceptable pharmaceutical excipient and wherein the pharmaceutical composition is free of binder. Manufacturing processes of such composition are also described…

USPTO Abstract

The present invention relates to a uniform pharmaceutical composition comprising dapagliflozin, metformin, at least one acceptable pharmaceutical excipient and wherein the pharmaceutical composition is free of binder. Manufacturing processes of such composition are also described.

Drugs covered by this patent

Patent Metadata

Patent number
EP4427742A1
Jurisdiction
EP
Classification
—
Expires
2024-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Galenicum Health SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.